Candida infections today - How big is the problem?

Acta Dermatovenerologica Croatica

Volumn 11, Issue 3, 2003, Pages 171-177

  Nola, Ivana ^a   Oremović, Lenka ^a   Kostović, Krešimir ^a   Soldo Belić, Antica ^a   Lugović, Liborija ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Antifungal agents; Candida; Candida albicans; Candidiasis; Causality

Indexed keywords

AMPHOTERICIN; CLOTRIMAZOLE; CORTICOSTEROID; ECONAZOLE; FLUCONAZOLE; IMIDAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NYSTATIN;

ANTIBIOTIC THERAPY; CANDIDA ALBICANS; CANDIDIASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNITY; INCIDENCE; LIFESPAN; LYMPHOCYTE FUNCTION; MICROFLORA; MUCOSA; MYCOSIS; NEUTROPHIL; ORGAN TRANSPLANTATION; PARENTERAL NUTRITION; REVIEW; SKIN DEFECT; STEROID THERAPY; T LYMPHOCYTE;

CANDIDIASIS; HUMANS; IMMUNOCOMPROMISED HOST; RISK FACTORS;

EID: 0141670331     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Braun-Falco O, Plewig G, Wolff HH, Winkelmann RK. Dermatomycoses. In: Braun-Falco O, Plewig G, Wolff HH, Winkelmann, editors. Dermatology. Berlin: Springer Verlag; 1991. p. 219-47.
2. Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg JM, Frak-Austen K. Dermatology in general Medicine. 4th ed. New York: McGraw-Hill; 1993.
3. Soldo I. Sistemne gljivične infekcije. In: Vrhovac B, editor. Interna medicina. Zagreb: Naprijed; 1991. p. 1565-7.
4. Du Vivier A, McKee PH. Solar damage and skin cancer. In: Anthony du Vivier. Atlas of clinical dermatology. 2nd ed. London: Dermatology Intrenational Ltd; 1998. p. 9.1-9.37.
5. Hay RJ, Moore M. Mycology. In: Rook A, Wilkinson DS, Ebling FJ, Champion RH, Burton JL, Breathnack SM, editors. Textbook of dermatology. 6th ed. Blackwell Scientific Publications; 1998. p. 1335-50.
6. Garber G. An overview of fungal infections. Drugs 2001;61 Suppl:l 1-2.
7. Rippon JW. Candidiasis and the pathogenic yeast. In: Medical mycology: the pathogenic and the pathogenic actinomycetes. Philadelphia: WB Saunders; 1982. p. 484.
8. Hopfer RI. Mycology of Candida infections. In: Bodey GP, Fainstein V, editors. Candidiasis. New York: Raven Press; 1985. p. 1.
9. De Bernardis F, Mondello F, San Millan R, Ponton J, Cassone A. Biotyping and virulence properties of skin isolates of Candida parapsilosis. J Clin I Microbiol 1999;37:3481-6.
10. Cotter G, Kavanagh K. Adherence mechanisms of Candida albicans. Br J Biomed Sci 2000;57:241-9.
11. Okeke CN, Tsuboi R, Kawai M, Yamazaki M, Reangchainam S, Ogawa H. Reverse transcription -3′ rapid amplification of cDNA ends-nested PCR of ACT1 and SAP2 mRNA as a means of detecting viable Candida albicans in an in vitro cutaneous candidiasis model. J Invest Dermatol 2000;114:95-100.
12. Kvaal C, Lachke SA, Srikantha T, Daniels K, McCoy J, Soll DR. Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection. Infect Immun 1999;67: 6652-62.
13. Scherwitz C. Ultrastructure of human cutaneous candidosis. J Invest Dermatol 2000;198:278.
14. Montes LF, Wilborn WH. Fungus-host relationship in candidiasis: a brief review. Arch Dermatol 1985;121: 119.
15. Simark-Mattsson C, Jontell M, Bergenholtz G, Dahlgren UI. Reduced in vivo cell-mediated immune responses to mumps, tuberculin, and streptokinase/streptodornase but not to Candida albicans in oral lichen planus. J Dent Res 1999;78:1704-10.
16. Savolainen J, Kosonen J, Lintu P, Viander M, Pene J, Kalimo K, et al. Candida albicans mannan- and protein-induced humoral, cellular and cytokine responses in atopic dermatitis patients. Clin Exp Allergy 1999; 29:824-31.
17. Abu-Elteen KH. Incidence and distribution of Candida species isolated from human skin in Jordan. Mycoses 1999;42:311-7.
18. Velegraki A, Nicolatou O, Theodoridou M, Mostrou G, Legakis NJ. Paediatric AIDS-related linear gingival erythema: a form of erythematous candidiasis? J Oral Pathol Med 1999;28:178-82.
19. Kimura M, Tsuruta S, Yoshida T. Measurement of Candida-specific lymphocyte proliferation by flow cytometry in children with atopic dermatitis. Arerugi 1998;47:449-56.
20. Kimura M, Tsuruta S, Yoshida T. IFN-gamma plays a dominant role in upregulation of Candida-specific IgE synthesis in patients with atopic dermatitis. Int Arch Allergy Immunol 2000;122:195-9.
21. Kimura M, Maeng DJ, Kobayashi M, Suto H, Ogawa H. Fungi and atopic dermatitis. Nippon Ishinkin Gakkai Zasshi 1999;40:79-83.
22. Arzumanyan VG, Magarshak OO, Semenov B. Yeast fungi in patients with allergic diseases: species variety and sensitivity to antifungal drugs. Bull Exp Biol Med 2000;19:601-4.
23. Morita E, Hide M, Yoneya Y, Kannbe M, Tanaka A, Yamamoto S. An assessment of the role of Candida albicans antigen in atopic dermatitis. J Dermatol 1999;26:282-7.
24. Adachi A, Horikawa T, Ichihashi M, Takashima T, Komura A. Role of Candida allergen in atopic dermatitis and efficacy of oral therapy with various antifungal agents. Arerugi 1999;48:719-25.
25. Lambiase MC. Candidiasis, cutaneous. Available at: http://www.emedicine.com/derm/topic67.htm. Accessed: July 3, 2003.
26. Dreizen S. Oral candidiasis. Am J Med 1984;77:28.
27. Nyquist G. A study of denture sore mouth: an investigation of traumatic, allergic and toxic lesions of the oral mucosa arising from the use of full denotures. Acta Odontal Scand 1952;10(Suppl 9):11.
28. Nyiresy P. Chronic vulvovaginal candidiasis. Am Fam Physician 2001;63:697-701.
29. Vazquez JA. Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients. HIV Clin Trials 2000;1:47-59.
30. Vazquez JA. Options for menagement of mucosal candidosis in patients with AIDS and HIV infections. Pharmacotherapy. 1999;19:76-87.
31. Grouhi M, Dalal I, Nisbet-Brown E, Roifman CM. Cerebral vasculitis associated with chronic mucocutaneous candidiasis. J Pediatr 1998;133:571-4.
32. Del Pozo MM, Bermejo F, Molina JA, de la Fuente EC, Martinez-Martin P, Benito-Leon J. Chronic neutrophilic meningitis caused by Candida albicans. Neurologia 1998;13:362-6.
33. De Andrade MF, Nishinari K, Puech-Leao P. Intertrigo in patients with lower limb lymphedema: clinical and laboratory correlation. Revista do Hospital das Clinicas; Faculdade de Medicina Da Universidade de Sao Paulo 1998;53:3-5.
34. Schaller M, Preidel H, Januschke E, Korting HC. Light and electron microscopic findings in a model of human cutaneous candidosis based on reconstructed human epidermis following the topical application of different econazole formulations. J Drug Target 1999;6:361-72.
35. Hazen KC. Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison. J Am Acad Dermatol 1998;38:S37-41.
36. Bryan MG. Candidiasis, chronic mucocutaneous. E-medicine. Available at: http//www.emedicine.com /derm/topic569.htm. Accessed: July 3, 2003.